Table 3.
Protective Effect of cIBR Peptide or CD11a mAb against MTX-cIBR Activity (1 μM).
| cIBR peptide [μM] | % Viable cells | CD11a antibody dose | % Viable cells |
|---|---|---|---|
| 10 | 58 ± 3 | 40 μL/mL | 35 ± 7 |
| 100 | 81 ± 7 | 80 μL/mL | 97 ± 10 |
| 1000 | 94 ± 5 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.